Bioresorbable Polymers Market Trends

INCREASING DEMAND FOR BIORESORBABLE POLYMERS FOR DRUG DELIVERY APPLICATION

Polymers have significantly contributed to the improvement of drug delivery technology by enabling the regulated release of therapeutic agents in consistent dosages over extended periods, cyclic dosing, and various releases of both hydrophilic and hydrophobic medicines. The area has expanded significantly from its early days of employing common materials. The rational design of polymers made to exert certain biological activities and customized for a specific cargo is currently the foundation for contemporary advancements in drug delivery.

Bioresorbable polymers provide monitored release to the needed site, stability to imbalanced molecules (e.g., proteins), and has ability to alter surfaces with ligands for secrecy and targeted drug delivery purposes in the human body.

In polymer therapies and nanomedicines, polymers have been used extensively. Solid, mostly spherical structures made from organic or

polymers are known as polymeric nanoparticles. One of the most significant biological uses of polymeric nanoparticles is drug delivery. A variety of drug delivery systems, including tiny hydrophilic and hydrophobic medicines, vaccines, peptides, and biological macromolecules, have been tested to deliver polymeric nanoparticles. The biodegradable polymers that produce polymeric nanoparticles most successfully include various grades of poly(lactide-co-glycolide) and poly(lactide) copolymers. Hence extensive properties of bioresorbable polymers for novel drug delivery systems, nanomedicines, and others will drive the bioresorbable polymers market in the forecast period.

Thus, increasing demand for drug delivery systems from the medical sector industry is a factor driving the growth of the Bioresorbable polymers market revenue.

In September 2023, Zeus, a leader in global advanced polymer solutions, announced that it had developed Absorv™ XSE oriented tubing. It is the latest addition to its portfolio of bioabsorbable products. Absorb XSE comes in different resins and expanded sizes, which make it highly customizable and an alternative to metallics implanted permanently within the human body. With this flexibility, medical device manufacturers can consider other applications of BRS beyond coronary artery disease treatment. Further developments can be made within the cardiovascular system, peripheral vascular system, and Ear Nose Throat (ENT), among others.

Evonik revealed the RESOMER Precise platform in June 2020, which represents a major advance in personalized functional polymeric excipients for custom drug products. With this technological novelty, pharmaceutical companies can develop parenteral drug delivery systems with unrivaled accuracy and precision in the control of their release profiles. In addition to improving drug product stability, the novel RESOMER platform also reduces regulatory risks associated with various complex parenteral drug products that are made using Evonik's advanced and unique process technology.

The Global Bioresorbable Polymers Market Industry is projected to experience substantial growth, with estimates indicating a rise from 1.59 USD Billion in 2024 to 6.71 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 14.01% from 2025 to 2035. Factors contributing to this expansion include increasing applications in the medical field, heightened environmental awareness, and ongoing technological advancements. As the industry evolves, it is likely to attract significant investments, further enhancing its growth potential. These projections underscore the importance of bioresorbable polymers in addressing contemporary challenges in sustainability and healthcare.

The Global Bioresorbable Polymers Market Industry experiences heightened demand in the medical sector, particularly for applications such as sutures, drug delivery systems, and orthopedic devices. Bioresorbable polymers offer the advantage of eliminating the need for surgical removal, thus enhancing patient comfort and reducing healthcare costs. For instance, the market is projected to reach 1.59 USD Billion in 2024, driven by innovations in biocompatible materials. As healthcare providers increasingly adopt these materials, the industry is likely to witness robust growth, indicating a shift towards more sustainable medical solutions.

Growing awareness regarding environmental sustainability significantly influences the Global Bioresorbable Polymers Market Industry. As industries seek alternatives to traditional plastics, bio-based polymers present a viable solution. These materials decompose naturally, reducing plastic waste and pollution. Governments worldwide are implementing regulations to promote biodegradable materials, further propelling market growth. The industry could potentially expand to 6.71 USD Billion by 2035, reflecting a compound annual growth rate of 14.01% from 2025 to 2035. This trend indicates a collective shift towards eco-friendly practices across various sectors, including packaging and consumer goods.

Consumer awareness regarding the benefits of bioresorbable polymers is on the rise, positively impacting the Global Bioresorbable Polymers Market Industry. As individuals become more informed about the environmental and health advantages of these materials, demand is likely to increase across various sectors. This shift in consumer behavior encourages manufacturers to adopt bio-based materials in their products, particularly in packaging and medical applications. The growing acceptance of bioresorbable polymers could lead to a broader market presence, fostering competition and innovation. Consequently, this trend may contribute to the industry's projected growth trajectory in the coming years.

The Global Bioresorbable Polymers Market Industry benefits from increased research and development activities aimed at exploring new applications and improving existing materials. Academic institutions and private companies are collaborating to innovate bioresorbable polymers with enhanced mechanical properties and degradation rates. This focus on R&D is crucial for meeting the diverse needs of various industries, including healthcare and packaging. As a result, the market is expected to see a steady influx of novel products, which could drive growth and expand the range of applications. This emphasis on innovation is likely to solidify the industry's position in the global market.

Technological innovations in the production of bioresorbable polymers are pivotal to the Global Bioresorbable Polymers Market Industry. Advances in polymer synthesis and processing techniques enhance the properties of these materials, making them more versatile for various applications. For example, improvements in 3D printing technology allow for the creation of customized bioresorbable implants, which can be tailored to individual patient needs. This adaptability is likely to attract more investments and research initiatives, thereby fostering market expansion. As these technologies evolve, the industry may witness a surge in applications across medical, pharmaceutical, and consumer sectors.

Major market players have large production bases and advanced manufacturing facilities at the domestic and international levels. This helps them supply the product to various end users across the globe within less time as compared to the small-scale manufacturers, providing a competitive edge in the market. The leading producers of merchant bioresorbable polymers are US, and Canada. According to MRFR analysis, the bioresorbable polymers market has a huge revenue base in European countries.

One of the primary business strategies adopted by manufacturers in the Bioresorbable polymers market to benefit clients and expand the Bioresorbable polymers market sector is to manufacture locally to reduce operating costs. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth.

Poly-Med Inc. is a leader in the design and production of bioresorbable products. The company operates in five business segments: Bioresorbable polymers, Biomedical textiles & Fiber, Electrospinning, Tissue scaffolds and devices, Polymer for Drug delivery, and 3D Printing Technology. Also, the company can provide customized solutions to meet the needs of innovative medical product manufacturers. Moreover, Poly-Med is the only vertically integrated company to deliver the highest quality solutions most efficiently.

Also, Merck KGaA is vibrant science and technology company with a diversified product portfolio. The company provides progressive treatment solutions that help improve access to health. Science sits inside technologies that drive human progress and opens new possibilities to transform lives. The advanced treatment solutions and innovative technology are life-changing, influencing to tackle of major illnesses and integral to creating a better tomorrow. The major business segments of the company are Life science, health care, and electronics.

Lygos Inc. launched its Soltellus line at NYSCC Suppliers' Day in May 2024; it was positioned as a high-performance, multi-functional, sustainable polymer for hair and skin care formulations. Skin care formulation under Soltellus acts as a co-surfactant with improved stability while providing a lathery, frothy foam that spreads easily and helps remove more dirt and oil impurities from deep pores. As an emulsifier, it improves user experience with a smoother application and luxurious after-feel, which keeps the formulation quality intact whilst ensuring the skin remains hydrated without any residue.